No Data
Express News | Minsheng Health: actively seeking new project opportunities in the big health field that are in line with the company's development global strategy and have rich synergies upstream and downstream.
People\'s Livelihood and Health: Report for the Third Quarter of 2024
Minsheng Health (301507.SZ): net income of 86.1784 million yuan in the first three quarters, a year-on-year increase of 5.52%.
Gelonghui, October 28th - Minsheng Health (301507.SZ) announced its third quarter report for 2024. In the first three quarters of 2024, the company achieved a revenue of 0.52 billion yuan, a year-on-year increase of 6.98%; the net income attributable to shareholders of the listed company was 86.1784 million yuan, a year-on-year increase of 5.52%; the net income after deducting non-recurring gains and losses was 82.3756 million yuan, a year-on-year increase of 9.30%; the basic earnings per share were 0.24 yuan per share.
Minsheng Health (301507.SZ): BASF (China) as a company's procurement supplier accounts for a relatively low proportion of the total annual procurement amount.
Gelonghui September 12th| Minsheng Health (301507.SZ) stated on the investor interaction platform that the company's current raw material procurement and supply, product manufacturing, and sales are all normal. The company's products are mostly composite preparations, generally requiring multiple raw materials, and fluctuations in the price of a single raw material have little impact on the overall cost of the company's products. BASF (China) as a company's procurement supplier accounts for a relatively low proportion of the total annual procurement amount, and the company's inventory reserves are relatively sufficient, which will not have a significant impact on the company's production operation and annual performance.
The market cap has dropped by more than 60% in the first year of listing, and Minh Health still relies on the large single product '21st Century Vitamins'.
In the first half of 2024, 21Vianet contributed nearly 80% of the listed company's revenue.
Minsheng Health (301507.SZ) 21.3933 million restricted shares will be listed for trading on September 5th.
Minsheng Health (301507.SZ) announced that the number of shares released prior to the company's initial public offering to lift restrictions this time is...
No Data
No Data